PortfoliosLab logoPortfoliosLab logo
AGI vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AGI vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alamos Gold Inc. (AGI) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AGI achieves a -8.58% return, which is significantly lower than TGTX's 66.12% return. Over the past 10 years, AGI has underperformed TGTX with an annualized return of 17.27%, while TGTX has yielded a comparatively higher 21.61% annualized return.


AGI

1D
2.06%
1M
-19.26%
YTD
-8.58%
6M
-8.36%
1Y
28.45%
3Y*
42.45%
5Y*
33.02%
10Y*
17.27%

TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AGI vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AGI
Alamos Gold Inc.
-8.58%109.93%37.72%34.33%33.11%-11.00%46.75%68.42%-44.49%-4.57%
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between AGI and TGTX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.05

The correlation between AGI and TGTX shifts across timeframes, from 0.05 (all time) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AGI:

$14.85B

TGTX:

$7.93B

EPS

AGI:

$2.52

TGTX:

$2.87

PE Ratio

AGI:

13.99

TGTX:

17.23

PEG Ratio

AGI:

0.09

TGTX:

0.03

PS Ratio

AGI:

7.19

TGTX:

11.37

PB Ratio

AGI:

3.21

TGTX:

13.59

Total Revenue (TTM)

AGI:

$2.07B

TGTX:

$700.35M

Gross Profit (TTM)

AGI:

$1.22B

TGTX:

$581.54M

EBITDA (TTM)

AGI:

$1.43B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AGI vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGI
AGI Risk / Return Rank: 5959
Overall Rank
AGI Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
AGI Sortino Ratio Rank: 5757
Sortino Ratio Rank
AGI Omega Ratio Rank: 5757
Omega Ratio Rank
AGI Calmar Ratio Rank: 5959
Calmar Ratio Rank
AGI Martin Ratio Rank: 6363
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AGI vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alamos Gold Inc. (AGI) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AGITGTXDifference
Sharpe ratioReturn per unit of total volatility

-0.14

Sortino ratioReturn per unit of downside risk

-0.27

Omega ratioGain probability vs. loss probability

1.13

1.16

-0.03

Calmar ratioReturn relative to maximum drawdown

0.71

1.00

-0.29

Martin ratioReturn relative to average drawdown

2.03

1.81

+0.22

AGI vs. TGTX - Sharpe Ratio Comparison

The current AGI Sharpe Ratio is 0.55, which is comparable to the TGTX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of AGI and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AGI vs. TGTX - Drawdown Comparison

The maximum AGI drawdown since its inception was -88.13%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for AGI and TGTX.


Loading charts...

Drawdown Indicators


AGITGTXDifference

Max Drawdown

Largest peak-to-trough decline

-88.13%

-99.52%

+11.39%

Max Drawdown (1Y)

Largest decline over 1 year

-40.29%

-32.66%

-7.63%

Max Drawdown (3Y)

Largest decline over 3 years

-40.29%

-75.42%

+35.13%

Max Drawdown (5Y)

Largest decline over 5 years

-40.29%

-90.75%

+50.46%

Max Drawdown (10Y)

Largest decline over 10 years

-71.13%

-93.19%

+22.06%

Current Drawdown

Current decline from peak

-36.25%

-78.79%

+42.54%

Average Drawdown

Average peak-to-trough decline

-37.73%

-91.43%

+53.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.05%

18.04%

-3.99%

Volatility

AGI vs. TGTX - Volatility Comparison

Alamos Gold Inc. (AGI) has a higher volatility of 17.80% compared to TG Therapeutics, Inc. (TGTX) at 15.65%. This indicates that AGI's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AGITGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.80%

15.65%

+2.15%

Volatility (6M)

Calculated over the trailing 6-month period

43.01%

34.28%

+8.73%

Volatility (1Y)

Calculated over the trailing 1-year period

51.64%

47.22%

+4.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.39%

87.77%

-46.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.44%

86.88%

-38.44%

Dividends

AGI vs. TGTX - Dividend Comparison

AGI's dividend yield for the trailing twelve months is around 0.37%, while TGTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AGI
Alamos Gold Inc.
0.37%0.26%0.54%0.74%0.99%1.30%0.74%0.66%0.56%0.31%0.29%1.22%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

AGI vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Alamos Gold Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M20222023202420252026
588.43M
204.92M
(AGI) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

AGI vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between Alamos Gold Inc. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
63.9%
83.7%
Portfolio components
AGI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alamos Gold Inc. reported a gross profit of 376.02M and revenue of 588.43M. Therefore, the gross margin over that period was 63.9%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

AGI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alamos Gold Inc. reported an operating income of 337.66M and revenue of 588.43M, resulting in an operating margin of 57.4%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

AGI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alamos Gold Inc. reported a net income of 188.75M and revenue of 588.43M, resulting in a net margin of 32.1%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


AGI and TGTX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AGI has higher volatility (17.80%) compared to TGTX (15.65%). In terms of maximum drawdown, AGI dropped -88.13% vs TGTX's -99.52%.

TGTX currently has the higher Sharpe Ratio (0.69 vs 0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AGI and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer